Nelson Advisors featured in Helm & Nagel : How AI is Dissolving the Boundaries Between Pharma and MedTech
NA
Nelson Advisors featured in Helm & Nagel : How AI is Dissolving the Boundaries Between Pharma and MedTech discussing Germany's Healthacre AI convergance.
'As artificial intelligence enables unprecedented data integration and collaborative workflows, traditional boundaries between pharmaceutical development and medical technology are being challenged. This transformation is particularly evident in Germany, where an unusual confluence of sectoral strengths creates opportunities for market leadership in AI-driven healthcare innovation.
Medical technology companies collaborate with pharmaceutical firms on AI-enhanced clinical trials, major pharmaceutical players integrate real-world evidence from medical devices into drug discovery, and biotech companies develop companion diagnostics alongside therapeutics. These patterns indicate systematic convergence.
Germany occupies a unique position at the intersection of three converging forces: world-leading pharmaceutical capabilities, Europe’s largest medical technology sector, and accelerating AI momentum. Realizing this potential requires strategic investment in the intersections between these traditionally separate domains.'
Source: https://helm-nagel.com/en/germanys-healthcare-ai-convergence/
Healthcare.digital. (2025, July 18). European HealthTech, Digital Health and Healthcare AI Exits in 2025: A Mid-Year Analysis and Outlook.